National Healthcare Properties (NASDAQ:NHP – Get Free Report) had its price target increased by research analysts at Robert W. Baird from $17.00 to $18.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s price target indicates a potential upside of 6.64% from the company’s previous close.
A number of other equities analysts have also recently issued reports on NHP. Morgan Stanley began coverage on National Healthcare Properties in a report on Monday, May 18th. They set an “equal weight” rating and a $16.00 price objective for the company. Citizens Jmp upped their price target on shares of National Healthcare Properties from $18.00 to $21.00 and gave the stock a “market outperform” rating in a report on Monday, August 10th. BMO Capital Markets began coverage on shares of National Healthcare Properties in a research note on Monday, May 18th. They issued a “market perform” rating and a $17.00 price target on the stock. Huntington assumed coverage on shares of National Healthcare Properties in a report on Friday, July 17th. They set an “outperform” rating and a $18.00 price objective for the company. Finally, National Bank Financial set a $18.00 price objective on shares of National Healthcare Properties in a research report on Thursday, May 28th. Six investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $18.00.
Check Out Our Latest Research Report on NHP
National Healthcare Properties Stock Up 1.8%
National Healthcare Properties (NASDAQ:NHP – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported ($0.13) earnings per share for the quarter. The business had revenue of $87.53 million during the quarter. National Healthcare Properties had a negative return on equity of 6.22% and a negative net margin of 13.04%.During the same quarter in the previous year, the company earned ($0.85) EPS. As a group, sell-side analysts expect that National Healthcare Properties will post 0.76 earnings per share for the current year.
Institutional Trading of National Healthcare Properties
An institutional investor recently bought a new position in National Healthcare Properties stock. Alyeska Investment Group L.P. purchased a new stake in National Healthcare Properties, Inc. (NASDAQ:NHP – Free Report) during the second quarter, according to its most recent filing with the SEC. The firm purchased 2,544,543 shares of the company’s stock, valued at approximately $37,278,000. Alyeska Investment Group L.P. owned 3.49% of National Healthcare Properties at the end of the most recent quarter.
About National Healthcare Properties
National Healthcare Properties Inc is a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing. National Healthcare Properties Inc is based in NEW YORK.
Recommended Stories
- Five stocks we like better than National Healthcare Properties
- One Platform, Every Ailment: Hinge Health’s Gamble
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
Receive News & Ratings for National Healthcare Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Healthcare Properties and related companies with MarketBeat.com's FREE daily email newsletter.
